CLBT
Cellebrite DI Ltd. Class A Ordinary Shares
$14.80+12.12% today
AI Take · AlgoThesis
Cellebrite's 51x P/E ratio stands as the headline grab here, nearly triple the typical software company multiple, yet the stock sits nowhere near its 52-week peak. With RSI at 63.6 signaling overbought conditions and a modest 3.33% short float offering minimal squeeze catalyst, the valuation disconnect becomes glaring—this appears to be a growth-at-any-cost narrative priced in aggressively despite recent pullback. The elevated multiple demands flawless execution and sustained margin expansion to justify current levels; any stumble in earnings growth could expose the premium as unsustainable.
Snapshot
Market cap
$3.3B
P/E
51.1
Forward P/E
23.5
EPS (TTM)
$0.29
Dividend yield
—
Net margin
14.5%
ROE
15.5%
RSI (14)
64
Beta
0.83
Short % of float
3.3%
Days to cover
2.3
52w high
50d high
Recent headlines
Build a thesis around CLBT
Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.
Open in AlgoThesis →